[HTML][HTML] Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease among children in the United States between …
KL Andrejko, R Gierke, JV Rowlands, JB Rosen… - Vaccine, 2024 - Elsevier
… , the incidence of invasive pneumococcal disease (IPD) among … of vaccine-type IPD (VT-IPD)
followed by increases in disease … In 2010, the 13-valent pneumococcal conjugate vaccine (…
followed by increases in disease … In 2010, the 13-valent pneumococcal conjugate vaccine (…
Early impact of 13-valent pneumococcal conjugate vaccine use on invasive pneumococcal disease among adults with and without underlying medical conditions …
SS Ahmed, T Pondo, W Xing, L McGee… - … Infectious Diseases, 2020 - academic.oup.com
… vaccine (PPSV23) in 2012. We evaluated PCV13 indirect effects on invasive pneumococcal
disease (IPD) among … In the US, 2 vaccines are licensed and recommended for prevention of …
disease (IPD) among … In the US, 2 vaccines are licensed and recommended for prevention of …
PCV15, a pneumococcal conjugate vaccine, for the prevention of invasive pneumococcal disease in infants and children
… the prevention of pneumonia, AOM, and invasive pneumococcal … Prevention of pneumococcal
disease among infants and children - use of 13-valent pneumococcal conjugate vaccine …
disease among infants and children - use of 13-valent pneumococcal conjugate vaccine …
Changes in invasive pneumococcal disease spectrum after 13-valent pneumococcal conjugate vaccine implementation
C Levy, E Varon, N Ouldali, S Béchet… - … Infectious Diseases, 2020 - academic.oup.com
… Pneumococcal conjugate vaccine (PCV) implementation has led to a sharp decrease in
invasive pneumococcal disease (… Pneumococcal conjugate vaccine (PCV) implementation has …
invasive pneumococcal disease (… Pneumococcal conjugate vaccine (PCV) implementation has …
Impact of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease after introduction into routine pediatric use
R Baxter, L Aukes, SI Pelton, A Yee… - … Infectious Diseases …, 2021 - academic.oup.com
… In 2010, the 13-valent pneumococcal conjugate vaccine (PCV13) replaced 7-valent PCV
(PCV7) for protection against invasive pneumococcal disease (IPD). This study used laboratory …
(PCV7) for protection against invasive pneumococcal disease (IPD). This study used laboratory …
Dynamics of invasive pneumococcal disease in Israel in children and adults in the 13-valent pneumococcal conjugate vaccine (PCV13) era: a nationwide prospective …
S Ben-Shimol, G Regev-Yochay… - … Infectious Diseases, 2022 - academic.oup.com
Background Following 13-valent pneumococcal conjugate vaccine (PCV13) implementation
in infants worldwide, overall and vaccine-type invasive pneumococcal disease (IPD) rates …
in infants worldwide, overall and vaccine-type invasive pneumococcal disease (IPD) rates …
Effectiveness of 10 and 13-valent pneumococcal conjugate vaccines against invasive pneumococcal disease in European children: SpIDnet observational multicentre …
C Savulescu, P Krizova, P Valentiner-Branth… - Vaccine, 2022 - Elsevier
… and PCV13 against invasive pneumococcal disease (IPD) in children of 12 European sites
(SpIDnet). … and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a …
(SpIDnet). … and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a …
[HTML][HTML] … tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 …
HL Platt, JF Cardona, M Haranaka, HI Schwartz… - Vaccine, 2022 - Elsevier
… was the only pneumococcal conjugate vaccine approved for … effective in preventing
vaccine-type (VT) pneumococcal, bacteremic, … PCV for the prevention of invasive and non-invasive …
vaccine-type (VT) pneumococcal, bacteremic, … PCV for the prevention of invasive and non-invasive …
[HTML][HTML] Burden of pneumococcal disease due to serotypes covered by the 13-valent and new higher-valent pneumococcal conjugate vaccines in the United States
L Huang, M Wasserman, L Grant, R Farkouh, V Snow… - Vaccine, 2022 - Elsevier
… (PD) in children and adults through direct and indirect protection. However… 13-valent PCV
(PCV13) formulation. To address this unmet need, 15-valent PCV (PCV15) and 20-valent PCV (…
(PCV13) formulation. To address this unmet need, 15-valent PCV (PCV15) and 20-valent PCV (…
Effectiveness of thirteen-valent pneumococcal conjugate vaccine to prevent serotype 3 invasive pneumococcal disease in Quebec in children, Canada
G Deceuninck, N Brousseau, B Lefebvre, C Quach… - Vaccine, 2023 - Elsevier
… of the 13-valent pneumococcal conjugate vaccine on serotype 3 Streptococcus pneumoniae
infections in … Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing …
infections in … Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing …